Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Onyebujoh

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Antimicrobial Agents and Chemotherapy|April 24, 2016
Erratum for Chirehwa et al., Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic ExtractionMaxwell T Chirehwa, Roxana Rustomjee, Thuli Mthiyane, et al.
Bulletin of the World Health Organization|November 23, 2005
Treatment of tuberculosis: present status and future prospectsPhilip Onyebujoh, Alimuddin Zumla, Isabella Ribeiro, et al.
The Lancet. Global Health|January 22, 2017
Sustainable clinical laboratory capacity for health in AfricaJustine Davies, Alash'le Abimiku, Moses Alobo, et al.
African Journal of Laboratory Medicine|September 8, 2017
The WHO AFRO external quality assessment programme (EQAP): Linking laboratory networks through EQA programmesDebrah I Boeras, Rosanna W Peeling, Philip Onyebujoh, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Pharmacokinetics of ethambutol and weight banded dosing in South African adults newly diagnosed with tuberculosis and HIVBonginkosi Ndzamba, Paolo Denti, Helen McIlleron, et al.
Tropical Medicine & International Health : TM & IH|August 25, 2010
Health services strengthening in Africa--research is a key componentShabbar Jaffar, Jeffrey V Lazarus, Philip Onyebujoh, et al.
BMC Research Notes|August 11, 2014
A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic settingWassihun Wedajo, Thomas Schön, Ahmed Bedru, et al.
The Lancet. Infectious Diseases|July 8, 2018
Laboratory medicine in Africa since 2008: then, now, and the futureJohn N Nkengasong, Francois-Xavier Mbopi-Keou, Rosanna W Peeling, et al.
The Lancet. Infectious Diseases|May 10, 2014
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trialSayoki G Mfinanga, Bruce J Kirenga, Duncan M Chanda, et al.
Plos Neglected Tropical Diseases|June 26, 2008
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research prioritiesDiana Boraschi, Markos Abebe Alemayehu, Abraham Aseffa, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Antimicrobial Agents and Chemotherapy|April 24, 2016
Erratum for Chirehwa et al., Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic ExtractionMaxwell T Chirehwa, Roxana Rustomjee, Thuli Mthiyane, et al.
Bulletin of the World Health Organization|November 23, 2005
Treatment of tuberculosis: present status and future prospectsPhilip Onyebujoh, Alimuddin Zumla, Isabella Ribeiro, et al.
The Lancet. Global Health|January 22, 2017
Sustainable clinical laboratory capacity for health in AfricaJustine Davies, Alash'le Abimiku, Moses Alobo, et al.
African Journal of Laboratory Medicine|September 8, 2017
The WHO AFRO external quality assessment programme (EQAP): Linking laboratory networks through EQA programmesDebrah I Boeras, Rosanna W Peeling, Philip Onyebujoh, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Pharmacokinetics of ethambutol and weight banded dosing in South African adults newly diagnosed with tuberculosis and HIVBonginkosi Ndzamba, Paolo Denti, Helen McIlleron, et al.
Tropical Medicine & International Health : TM & IH|August 25, 2010
Health services strengthening in Africa--research is a key componentShabbar Jaffar, Jeffrey V Lazarus, Philip Onyebujoh, et al.
BMC Research Notes|August 11, 2014
A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic settingWassihun Wedajo, Thomas Schön, Ahmed Bedru, et al.
The Lancet. Infectious Diseases|July 8, 2018
Laboratory medicine in Africa since 2008: then, now, and the futureJohn N Nkengasong, Francois-Xavier Mbopi-Keou, Rosanna W Peeling, et al.
The Lancet. Infectious Diseases|May 10, 2014
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trialSayoki G Mfinanga, Bruce J Kirenga, Duncan M Chanda, et al.
Plos Neglected Tropical Diseases|June 26, 2008
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research prioritiesDiana Boraschi, Markos Abebe Alemayehu, Abraham Aseffa, et al.
Pageof 2